270 related articles for article (PubMed ID: 12719580)
61. Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.
Saphire EO; Montero M; Menendez A; van Houten NE; Irving MB; Pantophlet R; Zwick MB; Parren PW; Burton DR; Scott JK; Wilson IA
J Mol Biol; 2007 Jun; 369(3):696-709. PubMed ID: 17445828
[TBL] [Abstract][Full Text] [Related]
62. Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.
Wu X; Zhou T; O'Dell S; Wyatt RT; Kwong PD; Mascola JR
J Virol; 2009 Nov; 83(21):10892-907. PubMed ID: 19692465
[TBL] [Abstract][Full Text] [Related]
63. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.
Kang CY; Hariharan K; Nara PL; Sodroski J; Moore JP
J Virol; 1994 Sep; 68(9):5854-62. PubMed ID: 7520095
[TBL] [Abstract][Full Text] [Related]
64. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
Yuan T; Li J; Zhang MY
MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
[TBL] [Abstract][Full Text] [Related]
65. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380
[TBL] [Abstract][Full Text] [Related]
66. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
67. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Zhou T; Xu L; Dey B; Hessell AJ; Van Ryk D; Xiang SH; Yang X; Zhang MY; Zwick MB; Arthos J; Burton DR; Dimitrov DS; Sodroski J; Wyatt R; Nabel GJ; Kwong PD
Nature; 2007 Feb; 445(7129):732-7. PubMed ID: 17301785
[TBL] [Abstract][Full Text] [Related]
68. Crystal structure of the principal neutralization site of HIV-1.
Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
[TBL] [Abstract][Full Text] [Related]
69. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries.
Barbas CF; Collet TA; Amberg W; Roben P; Binley JM; Hoekstra D; Cababa D; Jones TM; Williamson RA; Pilkington GR
J Mol Biol; 1993 Apr; 230(3):812-23. PubMed ID: 8478936
[TBL] [Abstract][Full Text] [Related]
70. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
[TBL] [Abstract][Full Text] [Related]
71. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
Pantophlet R; Wilson IA; Burton DR
Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540
[TBL] [Abstract][Full Text] [Related]
72. IgG1-b12-HIV-gp120 Interface in Solution: A Computational Study.
Martí D; Alemán C; Ainsley J; Ahumada O; Torras J
J Chem Inf Model; 2022 Jan; 62(2):359-371. PubMed ID: 34971312
[TBL] [Abstract][Full Text] [Related]
73. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
74. Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody.
Scharf L; West AP; Gao H; Lee T; Scheid JF; Nussenzweig MC; Bjorkman PJ; Diskin R
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6049-54. PubMed ID: 23524883
[TBL] [Abstract][Full Text] [Related]
75. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
[TBL] [Abstract][Full Text] [Related]
76. Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop.
Duarte CA; Pérez L; Vázquez J; Dueñas M; Vilarrubia OL; Navea L; Valdés R; Reyes O; Montero M; Ayala M; Gavilondo J
Immunotechnology; 1996 Feb; 2(1):11-20. PubMed ID: 9373324
[TBL] [Abstract][Full Text] [Related]
77. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.
He XM; Rüker F; Casale E; Carter DC
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7154-8. PubMed ID: 1496010
[TBL] [Abstract][Full Text] [Related]
78. HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.
Li Y; O'Dell S; Wilson R; Wu X; Schmidt SD; Hogerkorp CM; Louder MK; Longo NS; Poulsen C; Guenaga J; Chakrabarti BK; Doria-Rose N; Roederer M; Connors M; Mascola JR; Wyatt RT
J Virol; 2012 Oct; 86(20):11231-41. PubMed ID: 22875963
[TBL] [Abstract][Full Text] [Related]
79. A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
Zvi A; Tugarinov V; Faiman GA; Horovitz A; Anglister J
Eur J Biochem; 2000 Feb; 267(3):767-79. PubMed ID: 10651813
[TBL] [Abstract][Full Text] [Related]
80. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
Scheid JF; Mouquet H; Ueberheide B; Diskin R; Klein F; Oliveira TY; Pietzsch J; Fenyo D; Abadir A; Velinzon K; Hurley A; Myung S; Boulad F; Poignard P; Burton DR; Pereyra F; Ho DD; Walker BD; Seaman MS; Bjorkman PJ; Chait BT; Nussenzweig MC
Science; 2011 Sep; 333(6049):1633-7. PubMed ID: 21764753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
